February is not off to a good start in the USA with over 6,000 people dying of COVID-19 in the first two days
With statistics like these, what is taking the partner SI mentioned in the Edison video presentation for COVID-19 ARDS additional phase 3 trial so long to fund / start it ?
Where is the 12 month data for the first COVID-19 ARDS phase 3 trial ?
Monoclonal antibodies are now in limited use so again why is this process taking so long ?
https://www.fda.gov/news-events/pre...oclonal-antibodies-treat-covid-19-due-omicron
Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
Wed 2 Feb
Tue 1 Feb
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-139
-
- There are more pages in this discussion • 767 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |